RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 103 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $466,913 | -86.5% | 20,367 | -89.5% | 0.00% | -88.2% |
| Q1 2023 | $3,453,646 | -39.2% | 193,590 | -0.7% | 0.02% | -46.9% |
| Q4 2022 | $5,678,284 | -4.8% | 194,996 | -19.9% | 0.03% | 0.0% |
| Q3 2022 | $5,963,000 | +2699.5% | 243,408 | +3292.4% | 0.03% | +1500.0% |
| Q4 2020 | $213,000 | -73.4% | 7,175 | -80.6% | 0.00% | -71.4% |
| Q3 2020 | $801,000 | – | 36,969 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 810,000 | $19,845,000 | 8.20% |
| NEA Management Company, LLC | 4,912,306 | $108,316,000 | 5.41% |
| Frazier Life Sciences Management, L.P. | 1,894,000 | $46,403,000 | 3.57% |
| RA Capital Management | 5,471,067 | $134,041,000 | 2.86% |
| Samsara BioCapital, LLC | 345,293 | $8,460,000 | 1.97% |
| Altium Capital Management LP | 170,000 | $4,165,000 | 1.53% |
| Parkman Healthcare Partners LLC | 187,989 | $4,606,000 | 1.31% |
| Rock Springs Capital Management LP | 1,760,865 | $43,141,000 | 1.11% |
| EAM Investors, LLC | 198,699 | $4,868,000 | 1.06% |
| Prosight Management, LP | 80,000 | $1,960,000 | 1.05% |